Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

Share Price is delayed by 15 minutes
Get Live Data
160.00    0.00 (0.00%)
Bid:
120.00
Ask:
200.00
Spread: 80.00 (66.667%)
Market Cap: £77.39m
SPSC Live PriceLast checked at - London Stock Exchange

Intraday Spectra (di/ S) Share Chart

Second G8 Central Bank Test Program

13 Jan 2014 07:00

RNS Number : 4338X
Spectra Systems Corporation
13 January 2014
 



Spectra Systems Corporation ("Spectra Systems" or the "Company")

 

Second G 8 central bank test program for supercritical fluid cleaning of banknotes

 

The Board is delighted to announce that Spectra Systems has agreed to enter into a testing program scheduled to begin in April of this year, with a second G 8 central bank to evaluate its supercritical CO2 ("SCCO2") technology involving the use of supercritical fluids to clean heavily soiled banknotes, thereby allowing them to be returned to circulation and effectively increasing their life. This follows the ongoing trial with the first G8 central bank announced on 25 November 2013.

With banknote replacement costs approaching $10 billion annually, and most banknotes being replaced due to soiling, data from these central bank testing programs will be invaluable to the Company for determining the potential of this technology for creating a sizable revenue steam if adopted by major central banks. Spectra Systems will provide data to the industry from these trials at the Banknote 2014 conference in Washington DC commencing on 7 April 2014.

Spectra Systems also announces that its seminal work on the cleaning of soiled banknotes using SCCO2 has been published in the prestigious peer reviewed journal of the American Chemical Society, Industrial and Chemical Engineering Research. The paper, entitled "Supercritical Fluid Cleaning of Banknotes", is authored by Nabil M. Lawandy and Andrei Y. Smuk, Spectra's CEO and Director of Research and Development, respectively. The American Chemical Society has chosen to highlight this work in a featured press release http://www.acs.org/content/acs/en/pressroom.html) which has received broad coverage, including the Los Angeles Times (http://touch.latimes.com/#section/-1/article/p2p-78822882/) and other international news bureaus (see News section on the Company website: http://www.spectra-science.com/company-news.html)

 

Nabil Lawandy, Spectra System's CEO, stated:

"Spectra Systems is founded on cutting edge technology and the publication of our work in a leading scientific journal provides third party validation for its breakthrough technical results. The addition of a second G 8 central bank to the testing program will provide more data to help us formulate a compelling business proposition to the industry"

Enquiries:

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700

WH Ireland Limited

Chris Fielding (Head of Corporate Finance) Tel: +44 (0) 20 7220 1650

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBMMFTMBIBBBI
Date   Source Headline
5th Jan 20214:02 pmRNSDirectorate
5th Jan 20217:00 amRNSShare Buy-Back
14th Dec 20207:01 amRNSTwo Lottery Renewals
14th Dec 20207:00 amRNSAcquisition of interest - Solaris BioSciences, Inc
21st Oct 20209:06 amRNSSecond Price Monitoring Extn
21st Oct 20209:01 amRNSPrice Monitoring Extension
21st Oct 20207:00 amRNSContract with a Central Bank
14th Oct 20205:27 pmRNSHolding(s) in Company
6th Oct 20207:00 amRNSRemoval of Regulation S Restrictions
11th Sep 20204:34 pmRNSExercise of Options and Director/PDMR Shareholding
10th Sep 20207:00 amRNSExercise of Options and Director/PDMR Shareholding
7th Sep 20207:00 amRNSInterim Results for the Six Months 30 June 20
25th Aug 20204:11 pmRNSHolding(s) in Company
15th Jul 20206:25 pmRNSDirector Dealings
9th Jul 20207:00 amRNSContract with a Major Central Bank
26th Jun 20207:00 amRNSShare Buy-Back
25th Jun 20207:00 amRNSShare Buy-Back and Removal of Reg S Restrictions
16th Jun 20203:23 pmRNSShare Buy-Back
10th Jun 20207:00 amRNSAsian Central Bank Contract Update
26th May 20207:00 amRNSDirector Dealings
15th May 20205:24 pmRNSExercise of Options and Removal of Regulation S
30th Apr 20208:51 amRNSPosting of Annual Report and Accounts
3rd Apr 20204:56 pmRNSShare Buy-Back and Removal of Reg S Restrictions
23rd Mar 202012:37 pmRNSAudited Results
16th Mar 20201:59 pmRNSHolding(s) in Company
9th Mar 20204:41 pmRNSPrice Monitoring Extension
21st Feb 20207:00 amRNSShare Buy-Back
11th Nov 20193:30 pmRNSHolding(s) in Company
30th Oct 20191:39 pmRNSHolding(s) in Company
16th Oct 20197:00 amRNSHolding(s) in Company
25th Sep 20192:59 pmRNSHolding(s) in Company
24th Sep 20197:00 amRNSInterim Results
17th Sep 20197:00 amRNSFunding Approval - G7 Central Bank
1st Aug 20197:00 amRNSPolymer Banknote Substrate Supply Agreement
15th Jul 20197:00 amRNSNew Lottery Security Contracts
24th Jun 20197:00 amRNSAnnual General Meeting Lack of Quorum
11th Jun 20197:00 amRNSFive Year Optical Materials Supply Contract
29th May 20194:12 pmRNSExercise of Options
29th May 20197:00 amRNSTrading Update
28th May 20197:00 amRNSRemoval of Regulation S restrictions from shares
17th May 20193:21 pmRNSRemoval of Regulation S restrictions from shares
10th May 20192:31 pmRNSPosting of AGM Notice
10th May 20192:15 pmRNSShare Buy-Back
26th Apr 20198:55 amRNSPosting of Annual Report and Accounts
24th Apr 20197:00 amRNSRemoval of Regulation S Restrictions from Stock
18th Apr 20197:00 amRNSExercise of Options and Director/PDMR Shareholding
15th Apr 20197:00 amRNSUpdated CEO Employment Agreement
10th Apr 20197:00 amRNSShare Buy-Back Programme
25th Mar 20197:00 amRNSPreliminary Results
18th Mar 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.